カテゴリ： MarketLine, UAE, 企業調査

DAMAC Real Estate Development Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6092
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：UAE
◆産業分野：建設・建築
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

DAMAC Real Estate Development Ltd – Strategy, SWOT and Corporate Finance Report
Summary

DAMAC Real Estate Development Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DAMAC Real Estate Development Limited (DAMAC) is a subsidiary of DAMAC Properties Dubai Co PJSC, real estate development company. It principally focuses on developing properties such as residential luxury villas and apartments, leisure, mixed-use properties, hospitality and commercial properties. The company also has partnership with various brands such as FENDI Casa, Versace Home, Tiger Woods, Paramount Hotels & Resorts and The Trump Organization and offers highest standards of luxury properties to customers. It has operations in the UAE, Qatar, the UK, Saudi Arabia, Iraq, Jordan and Lebanon. DAMAC is a subsidiary of DAMAC Properties Dubai Co PJSC and headquartered in Dubai, the UAE.

Scope

- Detailed information on DAMAC Real Estate Development Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DAMAC Real Estate Development Ltd in the form of a SWOT analysis
- An in-depth view of the business model of DAMAC Real Estate Development Ltd including a breakdown and examination of key business segments
- Intelligence on DAMAC Real Estate Development Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DAMAC Real Estate Development Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DAMAC Real Estate Development Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DAMAC Real Estate Development Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DAMAC Real Estate Development Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
DAMAC Real Estate Development Ltd: Company Overview 9
DAMAC Real Estate Development Ltd: Overview and Key Facts 9
DAMAC Real Estate Development Ltd: Overview 9
DAMAC Real Estate Development Ltd: Key Facts 9
DAMAC Real Estate Development Ltd: Key Employees 10
DAMAC Real Estate Development Ltd: Key Employee Biographies 11
DAMAC Real Estate Development Ltd: Major Products and Services 12
DAMAC Real Estate Development Ltd: Company History 13
DAMAC Real Estate Development Ltd: Management Statement 16
DAMAC Real Estate Development Ltd: Locations and Subsidiaries 18
DAMAC Real Estate Development Ltd: Key Competitors 20
DAMAC Real Estate Development Ltd: Company Analysis 21
DAMAC Real Estate Development Ltd: Business Description 21
DAMAC Real Estate Development Ltd: SWOT Analysis 22
DAMAC Real Estate Development Ltd: SWOT Overview 22
DAMAC Real Estate Development Ltd: Strengths 22
DAMAC Real Estate Development Ltd: Weaknesses 23
DAMAC Real Estate Development Ltd: Opportunities 23
DAMAC Real Estate Development Ltd: Threats 24
DAMAC Real Estate Development Ltd: Corporate Financial Deals Activity 25
DAMAC Real Estate Development Ltd: Financial Deals Overview 25
DAMAC Real Estate Development Ltd: Top Deals 2014 – 2018YTD* 27
DAMAC Real Estate Development Ltd: Advisors 28
DAMAC Real Estate Development Ltd: Top Financial Advisors 28
DAMAC Real Estate Development Ltd: Capital Raising 29
DAMAC Real Estate Development Ltd: Recent Developments 30
DAMAC Real Estate Development Ltd: News and Events Summary 30
DAMAC Real Estate Development Ltd: Business Expansion 35
DAMAC Real Estate Development Ltd: Contracts 36
DAMAC Real Estate Development Ltd: Corporate Governance 37
DAMAC Real Estate Development Ltd: Financial Performance 37
DAMAC Real Estate Development Ltd: Strategy and Operations 38
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: DAMAC Real Estate Development Ltd: Key Facts
Table 2: DAMAC Real Estate Development Ltd: Key Employees
Table 3: DAMAC Real Estate Development Ltd: Company History
Table 4: DAMAC Real Estate Development Ltd: Locations and Subsidiaries
Table 5: DAMAC Real Estate Development Ltd: Key Competitors
Table 6: DAMAC Real Estate Development Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: DAMAC Real Estate Development Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: DAMAC Real Estate Development Ltd: Top Deals 2014 - 2018YTD*
Table 9: DAMAC Real Estate Development Ltd: Financial Advisor Ranking by Value (US$m)
Table 10: DAMAC Real Estate Development Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: DAMAC Real Estate Development Ltd: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: DAMAC Real Estate Development Ltd: News and Events Summary
Table 13: DAMAC Real Estate Development Ltd: Business Expansion
Table 14: DAMAC Real Estate Development Ltd: Contracts
Table 15: DAMAC Real Estate Development Ltd: Corporate Governance
Table 16: DAMAC Real Estate Development Ltd: Financial Performance
Table 17: DAMAC Real Estate Development Ltd: Strategy and Operations

List of Figures
Figure 1: DAMAC Real Estate Development Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: DAMAC Real Estate Development Ltd: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: DAMAC Real Estate Development Ltd: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: DAMAC Real Estate Development Ltd: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[DAMAC Real Estate Development Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Crossject SA (ALCJ)：企業の財務・戦略的SWOT分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company’s pipeline products include sumatriptan for the treatment of migraines and cluster headaches; adrenaline for the treatment of anaphylactic shock; hydrocortisone for the treatment of acute adrena …
  • Takara Holdings Inc (2531)：企業の財務・戦略的SWOT分析
    Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cavion LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Cavion LLC (Cavion), formerly Tau Therapeutics LLC is a clinical stage pharmaceutical company that develops modulators and drugs. The company researches and develops T-type calcium channel (Cav3) inhibitors for the treatment of neurologic and oncologic diseases. It provides pipeline products …
  • Atopix Therapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • ISA Pharmaceuticals BV：製薬・医療：M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • Archroma Pakistan Ltd (ARPL)：企業の財務・戦略的SWOT分析
    Archroma Pakistan Ltd (ARPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tokio Marine Holdings, Inc.：戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Encision Inc (ECIA)：企業の財務・戦略的SWOT分析
    Summary Encision Inc (Encision) is a medical device company that manufactures and markets surgical instruments. The company provides laparoscopic monopolar surgical instruments. Its product portfolio includes AEM burn protection systems, AEM instrumentation, cord adapter, inhibit adapter extension, …
  • Nanosonics Ltd (NAN)：企業の財務・戦略的SWOT分析
    Nanosonics Ltd (NAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BioStar Pharmaceuticals Inc (BSPM)：企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Fremont Michigan InsuraCorp Inc.：企業の戦略・SWOT・財務情報
    Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Fremont Michigan InsuraCorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Zoologischer Garten Berlin AG：企業の戦略・SWOT・財務情報
    Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report Summary Zoologischer Garten Berlin AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • China Merchants Securities Co Ltd (600999)：企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Lombard Odier Private Clients：企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Anagenesis Biotechnologies：製薬・医療：M&Aディール及び事業提携情報
    Summary Anagenesis Biotechnologies is a pharmaceutical solutions provider that offers treatment for muscle degenerative diseases. The company provides cell therapy genetics and pharmacological drugs for genetic and age related diseases. It also carries out cell-based technologies to provide solution …
  • Empire Co Ltd：戦略・SWOT・企業財務分析
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ENCE Energia Y Celulosa SA (ENC)：企業の財務・戦略的SWOT分析
    ENCE Energia Y Celulosa SA (ENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Adaptive Biotechnologies Corp：医療機器：M&Aディール及び事業提携情報
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories for conductin …
  • Air T Inc：企業の戦略・SWOT・財務分析
    Air T Inc - Strategy, SWOT and Corporate Finance Report Summary Air T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Sherwin-Williams Co (SHW)：企業の財務・戦略的SWOT分析
    Sherwin-Williams Co (SHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆